![](https://tracker.live.rns-distribution.com/track.live-rns/4966392_75d1671758db0ed18eba2dbba83793b2.png)
10 November 2023
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.
Mobius Investment Trust plc
(the "Company" or "MMIT")
Investment Manager Update
Mobius Investment Trust plc is pleased to announce its 5-Year anniversary with significant outperformance against the benchmark and its peer group in the period since the Company's IPO. This milestone underscores the Company's commitment to delivering sustainable outsized investment returns.
Founding Partner Dr Mark Mobius has notified the Company and the Company's Investment Manager, Mobius Capital Partners LLP ("MCP"), of his intention to step back from the partnership in the coming months, leaving a legacy of excellence and devotion to MCP and the Company. His contributions have been pivotal to the Company's success, and his approach of emerging market investing since the 1980s remains embedded in MCP's investment philosophy.
MMIT will continue to be managed by MCP, which is led by Carlos Hardenberg, supported by an experienced team of emerging markets specialists. Carlos has been investing in emerging markets and working closely with Dr Mobius for over 23 years. He successfully managed country, regional and global emerging and frontier market portfolios including the largest London listed emerging markets trust generating significant outperformance over the entire period.
Founding Partner Carlos Hardenberg said: "Our journey over the past five years has been marked by progress, and we are genuinely grateful for the results we have achieved. We would like to extend our heartfelt gratitude to Mark for his exceptional contributions to emerging market investing over his long career and more recently to MCP and MMIT over the last five years. Mark's dedication has been instrumental to our success. As we look forward to the future, I intend to promote our most talented employees to the role of partners. This is to acknowledge their strong performance and commitment to MCP."
Dr Mobius expressed his sentiments, commenting: "I am proud of the investment team's strong performance during the last five years which proves that a concentrated and differentiated portfolio of high-quality stocks can generate exceptional returns. As a shareholder of the MMIT, I will be following the Company's progress closely and will continue to be available to the team and the Board."
Speaking on behalf of the Board, Maria Luisa Cicognani, Chairman of MMIT, said: "Mark and Carlos have been instrumental to MMIT's success and outperformance since our IPO, and with Mark now intending to leave the partnership, we would like to express our immense gratitude to him for his advice and expertise over the years. We look forward to continuing to work with Mark, drawing on his support and vast knowledge of emerging markets, as MCP progresses with a strong and committed team led by Carlos which we are confident will continue to deliver outstanding results for our shareholders."
For further information please contact:
Mobius Capital Partners LLP Anna von Hahn
Camarco Eddie Livingstone Learmonth | Tel: +44 (0) 203 829 8500 Mob: +44 (0) 7852 882 770 Email: anna@mobiuscapitalpartners.com
Tel: +44 (0) 790 012 1128 Email: mobius@camarco.co.uk |
-ENDS-
Frostrow Capital LLP
Company Secretary
Tel: 020 3170 8732
Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.
LEI: 21380033EKFQS15X1W22
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.